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Towards a consensus around standards for smartphone apps 
and digital mental health
Mental disorders impact one in four people worldwide, yet 
access to care is challenging for those who suffer from them1. 
Mental health apps offer the potential to overcome access bar­
riers for the nearly three billion people projected to own a smart­
phone by 2020.
Although there are over 10,000 mental health apps commer­
cially available, there are few resources available to help end 
users (patients, clinicians and health care organizations) to eval­
uate the quality and suitability of these products. Thus, there is 
an urgent need for an agreement about appropriate standards, 
principles and practices in research and evaluation of these tools.
We represent leaders in mHealth research, industry and 
health care systems from around the globe, and we seek here 
to promote consensus on implementing these standards and 
principles for the evaluation of mental health apps. At a mini­
mum, standards should include consideration of: a) data safety 
and privacy, b) effectiveness, c) user experience/adherence, d) 
data integration. Our consensus on the challenges and recom­
mendations in each of these areas is presented below.
Data safety and privacy. Given the climate today regarding 
the misuse of online data such as email and social media, men­
tal health apps must ensure that data storage, use and shar­
ing practices fulfill health care standards for handling patient 
health information data2. Like with all sensitive health data, 
smartphones­based sensor data such as global positioning 
system (GPS), voice, keyboard usage, photos, video and overall 
phone usage behavior are features that many mental health 
apps collect, posing significant privacy challenges2,3.
Our recommendations are: a) agreed upon standards for data 
storage, use and sharing are needed; b) data storage, use and 
sharing policies must be made transparent to users of the app; 
c) if data are shared with external partners (e.g., researchers), 
the partner’s storage, use and sharing plans must be shared 
with the end user; d) the end user must have the option to “opt 
out” of sharing his/her information; e) any language regarding 
data storage, use and sharing must be written at a maximum of 
a 6th grade reading level; f ) technical security reviews and data 
audits are necessary to guarantee that apps follow the standards 
they set out and ensure that new vulnerabilities are quickly 
identified.
App effectiveness. Most mental health apps that are sold as 
therapeutic tools have not undergone rigorous evaluation, but 
instead claim that they are evidence based because they are 
informed by evidence based treatments4. Even when apps do 
have an evidence base, changes in technology may mean that 
app updates need to be re­evaluated for their efficacy. Small 
cosmetic changes, platform changes and aspect changes do 
not likely require a retest of an intervention, as long as the 
therapeutic principle that has been evaluated remains intact. 
Particularly where the aim is to increase reach, engagement 
and adherence rather than efficacy, A/B testing may be most 
appropriate. However, significant changes, such as adding a 
new therapeutic principle or substantial changes to that prin­
ciple, must demonstrate efficacy through the same evaluation 
pathways as novel therapeutics.
Our recommendations are: a) newly adapted therapeutic 
principles, which should be identified and defined, must un­
dergo controlled clinical trials to determine their efficacy and 
effectiveness; b) small changes to an app with an evidence base 
need not undergo another clinical trial, but any major change 
requires a re­evaluation of app effectiveness; c) a nosology for 
mental health apps5 and guidelines to match the necessary 
level of evidence for each app’s use cases and risks6 should be 
developed.
User experience/adherence. Many patient end users stop 
using a health app two weeks after download7. Clinician end 
user adherence is influenced by familiarity with technology 
and app match to the clinician’s therapeutic expertise. Lack of 
adherence is likely a function of app usability, as the input of 
clinician and patient end users is often missing when a mental 
health app is designed, resulting in apps that do not align with 
the preferences and goals of the intended users6.
Our recommendations are: a) user­centered/user experience 
(UX) design methods should be employed when creating an app; 
this includes involving the intended end user in the develop­
ment, and conducting as­is workflow analysis to ensure that the 
app is useful and usable, and that it fits into the fabric of the per­
son’s life, not producing unnecessary burden to the end user; b) 
when usability is evaluated, developers should report use statis­
tics to all end users; c) standards concerning best practice in user 
design research for mental health apps should be articulated.
Data integration. Apps should allow appropriate electronic 
health record (EHR) integration and sharing of health informa­
tion with clinicians. One challenge is that EHRs have non­uni­
form data integration requirements and not all support use of 
application programming interface (API) for data exchange. In 
the US, there is a strong move towards allowing patients access 
to their electronic health record information via SMART Health 
IT (https://apps.smarthealthit.org/), an open, standards­based 
technology platform that enables innovators to create apps 
that run across platforms. However, there are few agreed upon 
internal data standards to facilitate this level of interoperability.
Our recommendations are: a) mental health apps that are 
intended to be used in conjunction with health care systems 
should employ methods to ensure interoperability with elec­
tronic health records; b) mental health apps will need to docu­
ment the processes they use to ensure the secure exchange of 
information between platforms; c) internal data standards for 
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interoperability are needed, much like those outlined in http://
www.openmhealth.org/.
As mHealth transitions towards medical care in the mental 
health field, now is the critical moment for researchers, clini­
cians, service­users, policy makers and funders to guide that 
transition and ensure that these tools meet rigorous standards, 
as is required of any novel therapeutic.
Movement in this direction is taking place. In the US, the Food 
and Drug Administration has announced that it is moving away 
from evaluating individual apps, and focusing its regulatory ef­
forts on the app makers. Additionally, US professional groups like 
the American Psychiatric Association and the American Medical 
Association are creating app evaluation frameworks8. In the UK, 
the National Health Service has recently re­opened the App 
Library in beta phase, providing recommendations for apps across 
a range of conditions including mental health, and the British 
Standards Institute has published standards for health app devel­
opment. In the European Union, the National Institute of Health 
and Care Excellence (NICE) is actively developing standards for 
apps and other technology based behavioral change interventions.
We thus make a final recommendation that these organiza­
tions, and others, come together to set universal standards for 
mental health app quality control, and that those standards 
include at a minimum the review of data security, app effective­
ness, usability, and data integration.
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AVATAR therapy: a promising new approach for persistent 
distressing voices
AVATAR therapy was invented and first described by J. Leff 
and colleagues1. The therapy involves a three­way conversation 
between therapist, patient and a digital simulation (“avatar”) 
of one of his/her hallucinated voices. The avatar comprises a 
visual representation of the agent that the patient believes is 
responsible for the voice and uses a speech transformation 
software to change the therapist’s voice into a close match of 
the vocal characteristics (e.g., tone and pitch) of the voice that 
the patient has chosen for the therapy.
Therapy takes place over 6­8 short sessions of approximately 
45 min, of which around 15 min are spent in dialog with the av­
atar, and the rest reviewing the experiences of the previous week, 
planning the session and reviewing the experience after the di­
alog is complete. The therapist, sitting in a room remotely from 
the patient, speaks either as him/herself or in his/her trans­
formed voice as the avatar. The patient sits in front of a monitor 
on which the avatar appears. Starting with verbatim copies of 
what the patient reports hearing from his voices, the therapist 
adjusts what the avatar says according to the unfolding dialog, 
in which the patient is encouraged to confront the avatar and, 
through the dialog, to get to a point where it is no longer intimi­
dating and may even become encouraging and supportive.
The origins of the approach lie in dialogic therapies2­4 and is 
based on the observation that voices are best understood not 
simply as misattributions of internal thoughts, but represent 
hallucinated social entities that have personal relevance, mean­
ing and purpose5,6. Thus, the content of therapy is based on a 
formulation that takes account of the person’s beliefs about 
the identity, power and malevolence of the voices. It includes 
consideration of whether the voice is of someone he/she knows 
and whether what it says echoes earlier difficulties in relation­
ships, as for example experiences of being bullied, shamed or 
humiliated.
The therapy proceeds in two broad phases7. The first three 
sessions focus on assertively standing up to the avatar and re­
jecting its onslaught. The content of the second phase (sessions 
4 through 6) is more variable, as it is based on a formulation of 
what needs to change in the relationship and what might per­
suade the avatar to take a more conciliatory and accepting view 
of the person. Strategies to improve self­esteem have turned 
out to be a key target, both as an end in themselves and in the 
understanding of the origin and maintenance of the voice.
There have now been two pilot studies comparing AVATAR 
therapy to a waiting list control1,8 and one powered controlled 
